SGMOQ

0.10601.94%
HS

H. Stewart Parker

Independent Chairwoman of the Board

Ms. H. Stewart Parker, M.B.A., was Director of Inventprise, Inc. until July 2025. Ms. Parker is Independent Director at Codexis, Inc. since December 2022. She has been the Chairperson at Sangamo Therapeutics, Inc. since June 2017 and has been an Independent Director since June 2014. She is the Principal of Parker BioConsulting. Ms. Parker served as the Chief Executive Officer of Infectious Disease Research Institute (IDRI) from March 1, 2011 to December 2013. She served as the President and Chief Executive Officer of AmpliPhi Biosciences Corporation from 1989 to November 6, 2008 which she founded in 1992. She has over 30 years of industry experience. She served in various capacities at Immunex Corporation from August 1981 to December 1992 and served as its Vice President of corporate development. From February 1991 to January 1993, she served as President and Chief Executive Officer of Receptech Corp from February 1991 to January 1993. She served as President and Chief Executive Officer Immunex Corporation from 1992 to November 2008. Ms. Parker has executive leadership experience in development-stage clinical development, public company expertise and business development experience for pharmaceuticals and biologics. She served as Commercialization Consultant of The Washington Biotechnology & Biomedical Association (WBBA). Ms. Parker served as a Member of Executive Team of Attachmate Corporation. She served as an Executive Chairperson at Impel Pharmaceuticals Inc. (formerly known as Impel NeuroPharma, Inc.) She was the Chairperson of Armata Pharmaceuticals, Inc. (formerly C3J Therapeutics, Inc. (also known as C3 Jian, Inc)) since March 1, 2016 until 2019. She had been Director of Armata Pharmaceuticals, Inc. (formerly C3J Therapeutics, Inc.) since 2010 until December 09, 2020. She served as the Chairperson of CellExSys Inc., since December 2000. She has been an Independent Director of OncoGenex Pharmaceuticals, Inc. since March 23, 2010. She serves as a Director of WINGS. She serves as Member of Corporate Advisory Board at Adaptive Biotechnologies Corporation. She had been Director of Infectious Disease Research Institute (IDRI) since February 9, 2011 and was its strategic advisor. She had been an Independent Director of Impel Pharmaceuticals Inc. (formerly known as Impel NeuroPharma, Inc.) since May 2014 until April 10, 2023. She served as President and Chief Executive Officer of Targeted Genetics Corporation from 1992 to November 2008. She served on the Board of Directors of BIO. She had been an Independent Non-Employee Director at Achieve Life Sciences, Inc. since March 2010 until May 11, 2021. She serves as an Independent Director at StrideBio Inc. She serves as Director of C3 Jian, Inc. She serves as a Director at Nexgenia Inc. Ms. Parker serves a Director of US Bank Washington, Regence Washington Health, the University of Washington Arts & Sciences Advisory Council, the King Co. YMCA and Seattle Arts & Lectures. She also serves on the advisory Board of the University of Washington Foster School of Business and College of Arts & Sciences. She served as a Director of Immunex Corporation in 1992 to November 2008. In 1992 Ms. Parker founded Targeted Genetics Corporation and served as Director of Targeted Genetics Corporation from 1992 to November 2008. She served as a Director of AmpliPhi Biosciences Corporation from 1989 to November 14, 2008. She served as a Director of CellExSys Inc. and Receptech Corporation from 1991 to 1992. She served as a Director of Neose Technologies, Inc. since May 3, 2005 until January 2009. She served as a Board Member of the Seattle Branch of the Federal Reserve Bank of San Francisco. She served a Director of Biotechnology Innovation Organization. She is the recipient of several awards, including the Small Business Administrations 2001 Small Business Person of the Year for Western Washington and the Forum for Women Entrepreneurs Infectious Disease Research Institute 2001 Entrepre. Ms. Parker holds a B.A. in Slavic Language & Literature and an M.B.A. in Finance and International Business from the University of Washington.

Positions